tiprankstipranks
OncoCyte Corp (OCX)
NASDAQ:OCX

OncoCyte (OCX) Stock Forecast & Price Target

400 Followers
See the Price Targets and Ratings of:

OCX Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
OncoCyte
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OCX Stock 12 Month Forecast

There Are No Analyst Ratings for OCX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

OCX Financial Forecast

OCX Earnings Forecast

The previous quarter’s earnings for OCX were -$0.27.
The previous quarter’s earnings for OCX were -$0.27.

OCX Sales Forecast

The previous quarter’s earnings for OCX were $314.00K.
The previous quarter’s earnings for OCX were $314.00K.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Piper Sandler
$3.00
Hold
17.19%
Upside
Assigned
11/13/23
OncoCyte (OCX) Gets a Hold from Piper Sandler
Needham
$3.60
Buy
40.63%
Upside
Reiterated
11/09/23
We estimate OCX's cash runway to extend into 2H24. We have lowered our price target to $3.60 from $4.25 given peer multiple contraction.
Benchmark Co.
$5.00
Buy
95.31%
Upside
Reiterated
08/24/23
OncoCyte price target lowered to $5 from $9 at BenchmarkOncoCyte price target lowered to $5 from $9 at Benchmark

Best Analysts Covering OncoCyte

Which Analyst Should I Follow If I Want to Buy OCX and Sell After:
1 Month
Success Rate
5/17 ratings generated profit
29%
Average Return
-4.04%
reiterated a buy rating 6 months ago
Copying Michael Matson's trades and holding each position for 1 Month would result in 29.41% of your transactions generating a profit, with an average return of -4.04% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
3 Months
Success Rate
3/17 ratings generated profit
18%
Average Return
-20.02%
reiterated a buy rating 6 months ago
Copying Michael Matson's trades and holding each position for 3 Months would result in 17.65% of your transactions generating a profit, with an average return of -20.02% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
1 Year
Success Rate
0/17 ratings generated profit
0%
Average Return
-70.30%
reiterated a buy rating 6 months ago
Copying Michael Matson's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -70.30% per trade.
2 Years
Success Rate
0/17 ratings generated profit
0%
Average Return
-83.78%
reiterated a buy rating 6 months ago
Copying Michael Matson's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -83.78% per trade.
dummydummy
Success Rate
0/0 ratings generated profit
0%
Average Return
0.00%
a rating ―
Copying dummy's trades and holding each position for XXXX would result in 0.10% of your transactions generating a profit, with an average return of 0.00% per trade.
Premium Content
Find out which analyst has the highest Average Return & Success Rate
Go Premium
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OCX Analyst Recommendation Trends

Rating
Apr 23
May 23
Jul 23
Aug 23
Nov 23
Strong Buy
6
2
2
1
1
Buy
0
0
0
1
2
Hold
6
6
4
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
12
8
6
4
5
In the current month, OCX has received 3 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. OCX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

OCX Stock Forecast FAQ

What is OCX’s average 12-month price target, according to analysts?
Currently, no data Available
What is OCX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for OCX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is OCX a Buy, Sell or Hold?
      Currently, no data Available
      What is OncoCyte Corp’s price target?
      Currently, no data Available
      What do analysts say about OncoCyte Corp?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of OCX?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis